BioAnalysis launches BASIS 2.0, its next-gen GMP-compliant AUC software for gene therapy. Higher throughput, one-click ...
- A critical step for WuXi Vaccines to enable the manufacturing of commercial vaccine products in its Dundalk facility and supplying the global market for a top-10 pharmaceutical company DUNDALK, ...
The Hong Kong Science and Technology Parks Corporation (HKSTP) and the LKS Faculty of Medicine, the University of Hong Kong (HKUMed) today announced the launch of HKU-HKSTP Collaborative Programme and ...
52,000-square-foot corporate headquarters in San Diego with R&D and GMP manufacturing center Builds on current capability at Artiva’s partner, GC Cell’s facility in Republic of Korea Custom-built GMP ...
WILMINGTON, N.C.--(BUSINESS WIRE)--The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled a new clinical research laboratory building ...
A future of long-term, minimally toxic immunotherapy personalized to the cellular level is on the horizon—but only if manufacturers have the means to produce these therapies within a GMP environment.
InstantGMP Named #1 for EBR, LIMS & MES Integration Being recognized by Root Analysis as the number one provider of ...
Hosted on MSN
Mobilise App Lab IPO share allotment in focus today; GMP, how to check status in 5 steps
Mobilise App Lab IPO: The initial public offering (IPO) of software as a service IT solutions provider, Mobilise App Lab, concluded on Wednesday, February 25, with strong subscription of 100 times.
WuXi Vaccines, a global leading vaccines CDMO, announced that it has received the GMP certificate from Ireland Health Products Regulatory Authority (HPRA) for its QC potency lab in Dundalk, Ireland.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results